Nadia Cecconi

Nadia Cecconi

UNVERIFIED PROFILE

Are you Nadia Cecconi?   Register this Author

Register author
Nadia Cecconi

Nadia Cecconi

Publications by authors named "Nadia Cecconi"

Are you Nadia Cecconi?   Register this Author

22Publications

161Reads

38Profile Views

Interference of Monoclonal Gammopathy with Fibrinogen Assay Producing Spurious Dysfibrinogenemia.

TH Open 2019 Jan 19;3(1):e64-e66. Epub 2019 Mar 19.

Department of Clinical and Experimental Medicine, U.O. Hematology, University of Pisa, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-1683969DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524915PMC
January 2019

How to treat splenic marginal zone lymphoma (SMZL) in patients unfit for surgery or more aggressive therapies: experience in 30 cases.

J Chemother 2017 Apr 25;29(2):126-129. Epub 2016 Jul 25.

a Department of Oncology, Transplants and Advances in Medicine , Section of Hematology, University of Pisa , Pisa , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1120009X.2015.1114222DOI Listing
April 2017

Bortezomib and liposomal doxorubicin are highly effective in obtaining the best possible response before autologous transplant for multiple myeloma.

Acta Haematol 2009 29;122(1):39-41. Epub 2009 Aug 29.

Department of Oncology, Transplants and Advanced Technologies, Section of Hematology, Pisa University, Pisa, Italy.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/235819
Publisher Site
http://dx.doi.org/10.1159/000235819DOI Listing
November 2009

[An atypical case of cardiac amyloidosis].

Recenti Prog Med 2009 May;100(5):247-52

UOC Medicina Cardiovascolare e RM Lab, Fondazione G. Monasterio CNR-Regione Toscana, Pisa.

View Article

Download full-text PDF

Source
May 2009

Acute myeloid leukaemia after treatment with (90)Y-ibritumomab tiuxetan for follicular lymphoma.

Hematol Oncol 2008 Sep;26(3):179-81

Division of Hematology, Department of Oncology, Transplantations and New Technologies in Medicine, University of Pisa, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hon.849
Publisher Site
http://dx.doi.org/10.1002/hon.849DOI Listing
September 2008

Stable low IgG levels in relapsed non-Hodgkin's lymphomas.

Ann Hematol 2007 Nov 31;86(11):851-3. Epub 2007 May 31.

Department of Oncology, Transplant and Advances in Medicine, Section of Hematology, University of Pisa, Ospedale S Chiara, Via Roma, 67, 56100, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-007-0306-6DOI Listing
November 2007

Two cases of plasma cell leukemia with atypical immunophenotype.

Acta Haematol 2007 11;118(1):27-9. Epub 2007 Apr 11.

Department of Oncology, Transplants and Advanced Technologies, Section of Hematology, Pisa University, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000101557DOI Listing
July 2007

Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients.

Biomed Pharmacother 2005 Dec 21;59(10):541-4. Epub 2005 Oct 21.

Department of Internal Medicine, University of Pisa School of Medicine, Via Roma, 67, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopha.2004.12.003DOI Listing
December 2005

Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA.

Leuk Res 2005 Nov;29(11):1285-92

Department of Human Morphology and Applied Biology, University of Pisa, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2005.04.011DOI Listing
November 2005

Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H).

J Immunother 2004 Sep-Oct;27(5):389-93

Department of Oncology, Transplant and Advances in Medicine, Section of Hematology, University of Pisa, Pisa, Italy.

View Article

Download full-text PDF

Source
February 2005

Rituximab as treatment for minimal residual disease in hairy cell leukaemia.

Eur J Haematol 2004 Dec;73(6):412-7

Section of Hematology, Department of Oncology, Transplants and Advances in Medicine, University of Pisa, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2004.00325.xDOI Listing
December 2004

Efficacy and toxicity of liposomal daunorubicin included in PVABEC regimen for aggressive NHL of the elderly.

Leuk Lymphoma 2003 Mar;44(3):465-9

Department of Oncology, Division of Hematology, University of Pisa, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1042819021000037921DOI Listing
March 2003